U.S. Market for Drug-Eluting & Bare Metal Stents 2009
| Publication Date | May 2009 |
|---|---|
| Publisher | iData Research |
| Product Type | Report |
| Pages | 65 |
| ISBN Number | not applicable |
| Product Code | IDR00128 |
Buy this product or for assistance call +44 20 7060 7474
Summary
In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion, representing an increase of 1.6% over 2007. Overall average selling prices are predicted to decrease over the forecast period. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.
Content
Not Availble
Delivery Details
PDF:Dleivered by email within 4 to 24 hours during UK business hours (Mon-Fri)
PRINT/CD-ROM:Despatched by courier if outside Canada within 2 to 6 working days.
Related Products
Industry Events
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Best Practice in Phase IV Clinical & Observational Research
03 Dec 09 to 04 Dec 09
Prague, Czech Republic
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer? 
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories
